S.Res. 510 · 118th Congress · Senate

A resolution expressing the sense of the Senate that the scientific judgement of the Food and Drug Administration that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable and based on science.

Active· Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S6003-6004)
Introduced
Dec 14, 23
Passed Senate
Pending
Passed House
Pending
Sent to President
Pending
Signed into Law
Pending

Bill Text Versions

1

Introduced in Senate

Published: December 14, 2023

USLM Available
View Text